China repurposing pharma mega-factories to make novel foods, GFI report reveals
A new report shows that the expansion of biopharmaceuticals capacity in China and increased competition from biosimilars has encouraged some major manufacturers to explore novel foods by leveraging their existing fermentation capacity to produce mycoprotein, yeast proteins, and precision fermented fats...
